SDAD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.433600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.645600E-01
Normal-vs-Stage2
4.099800E-01
Normal-vs-Stage3
1.642590E-01
Normal-vs-Stage4
7.767000E-01
Stage1-vs-Stage2
3.613800E-01
Stage1-vs-Stage3
2.205600E-01
Stage1-vs-Stage4
4.511200E-01
Stage2-vs-Stage3
2.374600E-01
Stage2-vs-Stage4
1.469200E-01
Stage3-vs-Stage4
1.539970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.455800E-01
Normal-vs-AfricanAmerican
6.723000E-01
Normal-vs-Asian
3.280200E-01
Caucasian-vs-AfricanAmerican
7.557400E-01
Caucasian-vs-Asian
3.586800E-01
AfricanAmerican-vs-Asian
4.797000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.112000E-01
Normal-vs-Female
5.053200E-01
Male-vs-Female
3.871200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.987820E-01
Normal-vs-Age(41-60Yrs)
7.561200E-01
Normal-vs-Age(61-80Yrs)
3.210400E-01
Normal-vs-Age(81-100Yrs)
5.830000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.639200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.490400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.560200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.435810E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.955400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.308200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.847030E-01
Normal-vs-Daily Drinker
1.057400E-01
Normal-vs-Weekly Drinker
3.599400E-01
Normal-vs-Occasional Drinker
7.580800E-01
Normal-vs-Social Drinker
8.819200E-01
Non Drinker-vs-Daily Drinker
8.164200E-01
Non Drinker-vs-Weekly Drinker
7.185400E-01
Non Drinker-vs-Occasional Drinker
2.212200E-02
Non Drinker-vs-Social Drinker
5.179600E-02
Daily Drinker-vs-Weekly Drinker
5.844000E-01
Daily Drinker-vs-Occasional Drinker
8.996200E-03
Daily Drinker-vs-Social Drinker
3.528200E-02
Weekly Drinker-vs-Occasional Drinker
1.385590E-01
Weekly Drinker-vs-Social Drinker
2.213600E-01
Occasional Drinker-vs-Social Drinker
9.167000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.063800E-01
Normal-vs-Grade 2
5.570800E-01
Normal-vs-Grade 3
5.672000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.205200E-01
Grade 1-vs-Grade 3
4.491600E-01
Grade 1-vs-Grade 4
2.063800E-01
Grade 2-vs-Grade 3
5.138000E-01
Grade 2-vs-Grade 4
5.570800E-01
Grade 3-vs-Grade 4
5.672000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.547600E-01
Normal-vs-NonDiabetic
3.921000E-01
Diabetic-vs-NonDiabetic
3.817200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.264430E-01
Normal-vs-NoPancreatitis
3.960200E-01
Pancreatitis-vs-NoPancreatitis
6.635400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.482800E-01
Normal-vs-N1
4.210800E-01
N0-vs-N1
6.226000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.789800E-01
Normal-vs-TP53-NonMutant
7.093400E-01
TP53-Mutant-vs-TP53-NonMutant
3.829000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
